The DOI matches its Crossref record.
Tamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer
Abstract
Fifty-nine postmenopausal women with advanced breast cancer were treated with tamoxifen (antiestrogen), 20 mg orally twice a day for at least 2 months. They had been previously treated with other types of hormonal therapy or intensive chemotherapies, or both. Nineteen of the 59 patients (32%) had either a complete response (seven patients) or partial response (12 patients). The median duration of response was 9+ months. Tumors containing estrogen receptors and those that responded to previous hormonal manipulation tended to respond to tamoxifen (60% and 69%, respectively). Patients with receptor-negative tumor or with a history of failure of previous hormonal treatments did not respond to tamoxifen therapy. Tamoxifen is effective against advanced breast cancer. Side effects of the treatment were mild.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The pharmacology and clinical uses of tamoxifen
Furr, B. J. A., & Jordan, V. C. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90043-3 · Cited by 864
Tamoxifen: a most unlikely pioneering medicine
Jordan, V. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1031 · Cited by 824
Cancer of the Breast: The Past Decade
Henderson, I. C., & Canellos, G. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020104 · Cited by 467
Ingle, J. N., Ahmann, D. L., Green, S. J., Edmonson, J. H., Bisel, H. F., Kvols, L. K., Nichols, W. C., Creagan, E. T., Hahn, R. G., Rubin, J., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040104 · Cited by 336
Tamoxifen in advanced breast cancer
Mouridsen, H., Palshof, T., Patterson, J., & Battersby, L. (1978) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(78)80017-6 · Cited by 333
Metadata
- Authors
- KIANG, D. T., & KENNEDY, B.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1977-12-01
- Volume
- 87
- Issue
- 6
- Pages
- 687-690
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2067533672
- Cited by
- 166
- References
- 0
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer. https://app.cochat.ai/papers/10.7326/0003-4819-87-6-687
- The paper
- KIANG, D. T., & KENNEDY, B. (1977). Tamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-87-6-687
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.